Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesOphthalmology/OptometryPeach State Health Plan keratoplasty Coverage & Pr…
    Ask Trek AI about this page
    CurrentPeach State Health PlanPolicy CP.VP.36

    Keratoplasty (corneal transplant)

    Customize your policy alerts

    Sign up for Peach State Health Plan Policy CP.VP.36 alerts

    Get alerted when Policy CP.VP.36 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity criteria and coding guidance for corneal transplant procedures (keratoplasty) for members of Peach State Health Plan/affiliated Centene health plans. Applies to providers requesting coverage for corneal transplant procedures.

    Policy Summary
    PayerPeach State Health Plan
    PolicyKeratoplasty (corneal transplant)
    Policy CodePolicy CP.VP.36
    Change TypeNo material change
    Effective DateAug 1, 2025
    Last ReviewOct 1, 2025
    Next Review DateAug 1, 2025
    Key ActionObtain prior authorization per plan processes before submitting claims for keratoplasty procedures (CPT 65730, 65750, 65755, 65756, 65757).
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    10listed medically necessary indications

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    5CPT procedure codes referenced
    manyICD-10 diagnosis codes supporting coverage
    08/2025Last review date

    Coverage / Medical Necessity Criteria

    Medically Necessary Indications

    Keratoplasty is medically necessary for the following indications:

    Medically necessary indications

    • Indications list: Infectious corneal ulcers; Keratoconus; Bullous keratopathy; Previous failed grafts; Central corneal scars; Corneal dystrophies; Pellucid marginal degeneration; Descemetocele at risk of perforation; Corneal ectasia after LASIK; Corneal fibrosis

      Any single indication from this list meets the stated medical necessity criteria per the policy.

    The policy references specific Current Procedural Terminology (CPT) codes for keratoplasty (including 65730, 65750, 65755, 65756, and 65757) for informational purposes, but inclusion or exclusion of any CPT code in this clinical policy does not guarantee coverage. Providers must reference the plan's coverage determinations, benefit contract terms, and the most up-to-date professional coding guidance prior to claim submission and authorization requests.

    This policy does not state any explicit technique- or procedure-level exclusions declaring specific keratoplasty approaches as 'not medically necessary.' Coverage determinations are based on the listed medically necessary indications and the member's applicable benefit terms; the policy is intended as a guide to medical necessity rather than a guarantee of payment.

    Procedure and Diagnosis Coding

    Covered CPT CodesCPTCovered
    65730Keratoplasty (corneal transplant); penetrating (except in aphakia or pseudophakia).
    65750Keratoplasty (corneal transplant); penetrating (in aphakia).
    65755Keratoplasty (corneal transplant); penetrating (in pseudophakia).
    65756Keratoplasty (corneal transplant); endothelial.
    65757Backbench preparation of corneal endothelial allograft prior to transplantation (List separately in addition to code for primary procedure).
    ICD-10 diagnosis codes that support coverage (examples)ICD-10Covered
    H18.11Bullous keratopathy, right eye.
    H18.12Bullous keratopathy, left eye.
    H18.13Bullous keratopathy, bilateral.
    H18.611Keratoconus, stable, right eye.
    H18.612Keratoconus, stable, left eye.
    H18.613Keratoconus, stable, bilateral.
    H18.621Keratoconus, unstable, right eye.
    H18.622Keratoconus, unstable, left eye.
    H18.623Keratoconus, unstable, bilateral.
    H18.711Corneal ectasia, right eye.
    1–10 of 12
    1/2
    ICD-10 codes for complications/statusICD-10
    T85.318ABreakdown (mechanical) of other ocular prosthetic devices, implants and grafts, initial encounter.
    T85.318DBreakdown (mechanical) of other ocular prosthetic devices, implants and grafts, subsequent encounter.
    T85.318SBreakdown (mechanical) of other ocular prosthetic devices, implants and grafts, sequela.
    T85.328ADisplacement of other ocular prosthetic devices, implants and grafts, initial encounter.
    T85.328DDisplacement of other ocular prosthetic devices, implants and grafts, subsequent encounter.
    T85.328SDisplacement of other ocular prosthetic devices, implants and grafts, sequela.
    T86.8401Corneal transplant rejection, right eye.
    T86.8402Corneal transplant rejection, left eye.
    T86.8403Corneal transplant rejection, bilateral.
    T86.8411Corneal transplant failure, right eye.
    1–10 of 22
    1/3

    Provider Requirements and Operational Guidance

    Prior Authorization

    Prior authorization required for listed keratoplasty CPT codes

    Keratoplasty procedures listed in this policy (CPT 65730, 65750, 65755, 65756, 65757) require prior authorization per the plan's usual processes when requesting coverage for corneal transplant procedures.

    • CPT 65730 — Keratoplasty (corneal transplant); penetrating (except in aphakia or pseudophakia).
    • CPT 65750 — Keratoplasty (corneal transplant); penetrating (in aphakia).
    • CPT 65755 — Keratoplasty (corneal transplant); penetrating (in pseudophakia).
    • CPT 65756 — Keratoplasty (corneal transplant); endothelial.
    • CPT 65757 — Backbench preparation of corneal endothelial allograft prior to transplantation (List separately in addition to code for primary procedure).
    Step Therapy

    No step-therapy sequencing required before keratoplasty

    The policy does not impose step therapy or a required sequence of conservative treatments before keratoplasty; clinical background describes alternative surgical techniques and medical management options but does not mandate sequencing.

    Clinical Background

    Keratoplasty (corneal transplant) is a surgical procedure that replaces diseased or damaged corneal tissue with donor tissue to restore or preserve vision. Multiple techniques exist to address different layers and causes of corneal disease, including full‑thickness penetrating keratoplasty (PK), lamellar approaches such as DALK (deep anterior lamellar keratoplasty) when the endothelium is healthy, and endothelial procedures such as DSEK/DSAEK and DMEK that replace only the posterior corneal layers. Endothelial techniques are frequently preferred for primary endothelial disorders because they preserve corneal structure and often have superior visual outcomes and lower rejection risk compared with full‑thickness grafts; DALK reduces endothelial rejection risk for stromal disease but may have interface opacity risks. Postoperative management and documentation (for example, slit‑lamp examinations, suture management, and surveillance for rejection) are integral to patient care and to supporting coverage and ongoing treatment decisions.

    Procedure Definitions and Techniques

    DSEK / DSAEK — definition and clinical notes
    TermDSEK / DSAEK (Descemet's Stripping (Automated) Endothelial Keratoplasty)
    TechniqueEndothelial keratoplasty using a thin posterior graft (selective replacement of the diseased posterior cornea rather than full-thickness transplant)
    Clinical advantagesReported by AAO (2009) as superior to full-thickness penetrating keratoplasty (PK) for many endothelial disorders with better vision outcomes, improved stability, and fewer risk factors
    Indications / usePreferred option for disorders primarily affecting the corneal endothelium where replacement of a thin endothelial layer suffices
    Postoperative considerationsStandard postoperative monitoring with slit-lamp biomicroscopic examinations to assess graft clarity and suture status; suture management per topography and clinical findings

    Revision History

    2019-12Original approval

    Original approval of the Keratoplasty clinical policy (CP.VP.36).

    2020-05Template conversion

    Policy converted to new template.

    2020-12Annual review

    Annual review with added ICD-10 diagnosis codes.

    Policy Summary
    PayerPeach State Health Plan
    PolicyKeratoplasty (corneal transplant)
    Policy CodePolicy CP.VP.36
    Change TypeNo material change
    Effective DateAug 1, 2025
    Last ReviewOct 1, 2025
    Next Review DateAug 1, 2025
    Key ActionObtain prior authorization per plan processes before submitting claims for keratoplasty procedures (CPT 65730, 65750, 65755, 65756, 65757).
    SourceLink
    On This Page
    Coverage / Medical Necessity CriteriaProcedure and Diagnosis CodingProvider Requirements and Operational GuidanceClinical BackgroundProcedure Definitions and TechniquesRevision History
    • Clinical alternatives discussed include DSEK/DSAEK/DMEK (endothelial procedures) and DALK (deep anterior lamellar keratoplasty).
    • Medical management of graft rejection (topical/oral corticosteroids, subconjunctival or sub-Tenon's injections) is described but not required as a prior step to surgery.
    Documentation Required

    Document postoperative exams, suture management, and graft rejection monitoring

    Postoperative clinical documentation is expected to include slit-lamp biomicroscopic examinations to assess corneal clarity and graft health, monitoring for suture erosion and timing of selective suture removal, and documentation of signs or symptoms of graft rejection and their management.

    • Perform and document slit-lamp biomicroscopic exams to assess corneal clarity, graft status, and suture condition.
    • Document selective suture removal decisions (typically beginning after three months) guided by topography and wound stability, and note any earlier removal for loose sutures or suture erosion.
    • Document patient counseling on rejection warning signs (redness, photophobia, vision change, pain) and any therapeutic interventions for rejection (topical/oral corticosteroids; subconjunctival or sub‑Tenon's injections).
    Billing Rule

    Coding/capture risk — codes in policy are informational only

    Inclusion or exclusion of CPT codes in this policy does not guarantee coverage; providers must reference current coding guidance before claim submission and recognize that listed codes are informational.

    • Codes in the policy are provided for informational purposes only and are not all‑inclusive.
    • Providers should consult the most up-to-date professional coding sources prior to submission of reimbursement claims.
    DALK — definition and clinical notes
    TermDALK (Deep Anterior Lamellar Keratoplasty)
    TechniqueSurgical removal of the corneal stroma down to Descemet's membrane while preserving the recipient Descemet's membrane and endothelium
    Clinical advantagesUseful when the endothelium is healthy to reduce risk of graft rejection compared with full-thickness penetrating keratoplasty (PK)
    Risks / limitationsPotential for decreased visual acuity due to interface opacity between graft and host layers
    Indications / usePreferred for stromal corneal disease where preserving host endothelium is desirable to lessen rejection and related complications
    2021-12Annual review

    Annual review performed.

    2022-01Approval

    Policy approval following annual review.

    2022-11Annual review

    Annual review performed.

    2022-12Approval

    Policy approval following annual review.

    2023-11Annual review

    Annual review performed.

    2023-12Approval

    Policy approval following annual review.

    2024-11Annual review

    Annual review with updated references.

    2024-12Approval

    Policy approval following annual review and reference updates.

    2025-08Annual reviewLatest

    Annual review performed; Last Review Date recorded as 08/2025.